Clovis Oncology (CLVS) stock Forecast for 2022 – 2026

Clovis Oncology (CLVS) stock Forecast for 2022 – 2026

Last update: 05-24-2022, 6:24

Sector: Healthcare

The share price of Clovis Oncology, Inc. (CLVS) now

What analysts predict:: $3

52-week high/low: $7.24 / $0.695

50/200 Day Moving Average: $1.796 / $3.05

This figure corresponds to the average price over the previous 50/200 days. For Clovis Oncology stocks, the 50-day moving average is the resistance level today.

For Clovis Oncology stocks, the 200-day moving average is the resistance level today.

Are you interested in Clovis Oncology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Clovis Oncology stock price in 2022, 2023, 2024, 2025, 2026. How much will one Clovis Oncology share be worth in 2022 - 2026?

When should I take profit in Clovis Oncology stock? When should I record a loss on Clovis Oncology stock? What are analysts' forecasts for Clovis Oncology stock? What is the future of Clovis Oncology stock?

We forecast Clovis Oncology stock performance using neural networks based on historical data on Clovis Oncology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Clovis Oncology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Clovis Oncology shares. This happens once a day.




Historical and forecast chart of Clovis Oncology stock

The chart below shows the historical price of Clovis Oncology stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Clovis Oncology stock price can be found in the table below.

Long-term forecasts by years.

Clovis Oncology daily forecast for a month

Date Target Pes. Opt. Vol., %
May 26 0.67 0.65 0.69 4.64
May 27 0.69 0.68 0.72 6.15
May 28 0.71 0.69 0.74 6.87
May 29 0.67 0.65 0.70 7.02
May 30 0.67 0.65 0.69 5.60
May 31 0.67 0.66 0.68 2.74
Jun 01 0.66 0.64 0.68 6.03
Jun 02 0.67 0.64 0.69 6.73
Jun 03 0.70 0.66 0.71 6.79
Jun 04 0.66 0.64 0.67 4.04
Jun 05 0.66 0.63 0.67 6.61
Jun 06 0.69 0.68 0.71 5.55
Jun 07 0.68 0.65 0.71 8.01
Jun 08 0.72 0.69 0.73 5.56
Jun 09 0.70 0.68 0.73 7.52
Jun 10 0.70 0.68 0.73 7.68
Jun 11 0.68 0.66 0.70 5.92
Jun 12 0.70 0.68 0.71 3.86
Jun 13 0.66 0.63 0.68 8.53
Jun 14 0.68 0.65 0.70 7.80
Jun 15 0.67 0.64 0.70 9.30
Jun 16 0.67 0.64 0.69 6.87
Jun 17 0.71 0.69 0.72 3.42
Jun 18 0.75 0.73 0.76 4.31
Jun 19 0.74 0.72 0.76 6.51
Jun 20 0.76 0.74 0.78 5.51
Jun 21 0.76 0.73 0.77 5.17
Jun 22 0.75 0.74 0.79 6.75
Jun 23 0.73 0.71 0.74 5.06
Jun 24 0.74 0.72 0.75 3.50

Clovis Oncology Daily Price Targets


Clovis Oncology Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $0.67. Negative dynamics for Clovis Oncology shares will prevail with possible volatility of 4.431%.

Pessimistic target level: 0.65

Optimistic target level: 0.69


Clovis Oncology Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $0.69. Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 5.795%.

Pessimistic target level: 0.68

Optimistic target level: 0.72


Clovis Oncology Stock Forecast 05-28-2022.

Forecast target price for 05-28-2022: $0.71. Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 6.427%.

Pessimistic target level: 0.69

Optimistic target level: 0.74


Clovis Oncology Stock Forecast 05-29-2022.

Forecast target price for 05-29-2022: $0.67. Negative dynamics for Clovis Oncology shares will prevail with possible volatility of 6.561%.

Pessimistic target level: 0.65

Optimistic target level: 0.70


Clovis Oncology Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $0.67. Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 5.301%.

Pessimistic target level: 0.65

Optimistic target level: 0.69


Clovis Oncology Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $0.67. Negative dynamics for Clovis Oncology shares will prevail with possible volatility of 2.666%.

Pessimistic target level: 0.66

Optimistic target level: 0.68


CLVS (CLVS) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 0.68 0.58 0.74 22.19
Jul. 0.67 0.59 0.77 23.54
Aug. 0.74 0.66 0.81 18.15
Sep. 0.60 0.49 0.72 32.08
Oct. 0.68 0.56 0.83 31.78
Nov. 0.86 0.75 1.05 28.27
Dec. 0.82 0.71 0.98 27.96

Clovis Oncology forecast for this year


Clovis Oncology Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $0.675352. Pessimistic: $0.58. Optimistic: $0.74


Clovis Oncology Stock Prediction for Jul 2022

An downtrend is forecast for this month with an optimal target price of $0.67157. Pessimistic: $0.59. Optimistic: $0.77


Clovis Oncology Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $0.737384. Pessimistic: $0.66. Optimistic: $0.81


Clovis Oncology Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $0.601116. Pessimistic: $0.49. Optimistic: $0.72


Clovis Oncology Stock Prediction for Oct 2022

An uptrend is forecast for this month with an optimal target price of $0.683589. Pessimistic: $0.56. Optimistic: $0.83


Clovis Oncology Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $0.863509. Pessimistic: $0.75. Optimistic: $1.05


Clovis Oncology Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $0.817571. Pessimistic: $0.71. Optimistic: $0.98




Clovis Oncology (CLVS) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 0.82 0.67 0.87 23.07
Feb 0.78 0.61 0.87 30.41
Mar 0.91 0.76 1.08 29.85
Apr 0.90 0.83 1.05 20.86
May 0.71 0.58 0.83 30.47
Jun 0.90 0.75 0.98 24.22
Jul 1.16 1.03 1.24 17.23
Aug 1.27 1.20 1.52 21.30
Sep 1.30 1.07 1.49 28.46
Oct 1.57 1.34 1.71 21.64
Nov 1.74 1.37 2.12 35.54
Dec 1.98 1.72 2.39 28.07

Clovis Oncology (CLVS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 1.46 1.24 1.55 20.05
Feb 1.15 1.03 1.22 15.38
Mar 1.31 1.14 1.49 23.77
Apr 0.94 0.78 1.13 31.46
May 0.93 0.84 1.09 22.85
Jun 0.89 0.77 1.07 27.90
Jul 1.12 1.05 1.36 22.63
Aug 1.17 0.96 1.26 23.81
Sep 1.05 0.88 1.19 26.29
Oct 0.80 0.71 0.92 22.68
Nov 0.89 0.71 0.96 26.47
Dec 0.97 0.78 1.05 25.45



Clovis Oncology (CLVS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 1.08 0.85 1.25 31.87
Feb 1.06 0.98 1.12 12.99
Mar 1.17 0.96 1.42 32.47
Apr 1.04 0.87 1.26 31.25
May 1.00 0.82 1.11 26.00
Jun 0.96 0.86 1.04 17.52
Jul 1.06 0.84 1.13 26.03
Aug 0.96 0.78 1.13 31.25
Sep 0.73 0.65 0.83 21.67
Oct 0.83 0.76 0.95 19.75
Nov 0.76 0.64 0.84 23.85
Dec 0.73 0.58 0.84 31.28

Clovis Oncology (CLVS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.83 0.67 0.92 27.77
Feb 0.76 0.60 0.84 27.73
Mar 0.74 0.66 0.82 19.44
Apr 0.77 0.64 0.87 26.36
May 0.75 0.69 0.88 20.76
Jun 0.72 0.59 0.85 30.56
Jul 0.74 0.57 0.79 26.95
Aug 0.74 0.66 0.80 17.27
Sep 0.55 0.49 0.61 19.54
Oct 0.57 0.45 0.64 30.61
Nov 0.42 0.36 0.49 26.08
Dec 0.31 0.28 0.35 21.12

Clovis Oncology information and performance

Clovis Oncology, Inc., a biopharmaceutical company, specializes in the acquisition, development and commercialization of anti-cancer agents in the United States, the European Union and internationally. The company offers Rubraca (rucaparib), an oral small molecule poly-ADP-ribose polymerase inhibitor for the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Clovis Oncology Address

5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO, US

Market Capitalization: 106 485 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -358 064 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.13

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.29

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: -0.169

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.489

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 143879000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.